Evolving Chemotherapy for Advanced Gastric Cancer

Evolving Chemotherapy for Advanced Gastric Cancer Jaffer A. Ajani Oncologist 2005; 10: 49-58 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gastrointestinal cancer and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Identify the current standard of care and new chemotherapy options for patients with advanced gastric cancer. Discuss recently reported results of phase II and phase III randomized trials of chemotherapy for the treatment of advanced gastric cancer. Outline the clinical implications of recent clinical trial findings and future treatment strategies. Describe regimens that have quality-of-life benefits for patients with advanced gastric cancer and how patients should be selected and managed appropriately. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Dec. 19, 2005 Most Recent Review: Dec. 19, 2005* Most Recent Update: Dec. 19, 2005 Date Credit Expires: Dec. 19, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.